ATE396192T1 - N-sulfonylaminothiazole - Google Patents
N-sulfonylaminothiazoleInfo
- Publication number
- ATE396192T1 ATE396192T1 AT03779918T AT03779918T ATE396192T1 AT E396192 T1 ATE396192 T1 AT E396192T1 AT 03779918 T AT03779918 T AT 03779918T AT 03779918 T AT03779918 T AT 03779918T AT E396192 T1 ATE396192 T1 AT E396192T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfonylaminothiazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0226616A GB0226616D0 (en) | 2002-11-14 | 2002-11-14 | Organic compounds |
GB0226602A GB0226602D0 (en) | 2002-11-14 | 2002-11-14 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE396192T1 true ATE396192T1 (de) | 2008-06-15 |
Family
ID=32313994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03779918T ATE396192T1 (de) | 2002-11-14 | 2003-11-13 | N-sulfonylaminothiazole |
Country Status (16)
Country | Link |
---|---|
US (1) | US7291734B2 (de) |
EP (1) | EP1562958B1 (de) |
JP (1) | JP4551767B2 (de) |
AR (1) | AR041952A1 (de) |
AT (1) | ATE396192T1 (de) |
AU (1) | AU2003288056A1 (de) |
BR (1) | BR0316205A (de) |
CA (1) | CA2505249A1 (de) |
DE (1) | DE60321209D1 (de) |
ES (1) | ES2305542T3 (de) |
HK (1) | HK1081541A1 (de) |
MY (1) | MY135750A (de) |
PE (1) | PE20040693A1 (de) |
PT (1) | PT1562958E (de) |
TW (1) | TWI318212B (de) |
WO (1) | WO2004043968A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2570994A1 (en) * | 2004-06-30 | 2006-02-02 | Merck & Co., Inc. | Estrogen receptor modulators |
GB0505541D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
GB0505539D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
EP2207544A2 (de) | 2007-09-17 | 2010-07-21 | PregLem S.A. | Behandlung von östrogen-abhängigen erkrankungen bei premenopausalen frauen |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1620508A1 (de) | 1965-07-23 | 1969-09-18 | Thomae Gmbh Dr K | Verfahren zur Herstellung neuer 4,5,6,7-Tetrahydrothiazolo-[5,4-c]-pyridine |
DE2429195A1 (de) | 1974-06-18 | 1976-02-05 | Basf Ag | 2-amino-pyrazolo eckige klammer auf 3,4-d eckige klammer zu thiazole |
GB8333514D0 (en) * | 1983-12-16 | 1984-01-25 | Erba Farmitalia | Tetrahydrothiazolo(5 4-c)pyridine derivatives |
DE3533331A1 (de) * | 1985-09-18 | 1987-03-26 | Heumann Ludwig & Co Gmbh | Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
CO5261573A1 (es) * | 1999-11-19 | 2003-03-31 | Novartis Ag | Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion |
JP2001294572A (ja) * | 2000-02-09 | 2001-10-23 | Dai Ichi Seiyaku Co Ltd | 新規スルホニル誘導体 |
SE0001899D0 (sv) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
EP1578341A2 (de) | 2000-10-11 | 2005-09-28 | Tularik Inc. | Modulation der ccr4-funktion |
JP4266092B2 (ja) | 2001-10-09 | 2009-05-20 | 第一三共株式会社 | ジアミン誘導体 |
-
2003
- 2003-11-12 PE PE2003001143A patent/PE20040693A1/es not_active Application Discontinuation
- 2003-11-12 AR ARP030104165A patent/AR041952A1/es not_active Application Discontinuation
- 2003-11-13 US US10/533,335 patent/US7291734B2/en not_active Expired - Fee Related
- 2003-11-13 AU AU2003288056A patent/AU2003288056A1/en not_active Abandoned
- 2003-11-13 JP JP2004551017A patent/JP4551767B2/ja not_active Expired - Fee Related
- 2003-11-13 WO PCT/EP2003/012707 patent/WO2004043968A1/en active IP Right Grant
- 2003-11-13 BR BR0316205-2A patent/BR0316205A/pt not_active IP Right Cessation
- 2003-11-13 MY MYPI20034348A patent/MY135750A/en unknown
- 2003-11-13 EP EP03779918A patent/EP1562958B1/de not_active Expired - Lifetime
- 2003-11-13 TW TW092131800A patent/TWI318212B/zh not_active IP Right Cessation
- 2003-11-13 ES ES03779918T patent/ES2305542T3/es not_active Expired - Lifetime
- 2003-11-13 AT AT03779918T patent/ATE396192T1/de not_active IP Right Cessation
- 2003-11-13 PT PT03779918T patent/PT1562958E/pt unknown
- 2003-11-13 CA CA002505249A patent/CA2505249A1/en not_active Abandoned
- 2003-11-13 DE DE60321209T patent/DE60321209D1/de not_active Expired - Lifetime
-
2006
- 2006-02-06 HK HK06101572A patent/HK1081541A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1081541A1 (en) | 2006-05-19 |
EP1562958B1 (de) | 2008-05-21 |
JP2006507321A (ja) | 2006-03-02 |
JP4551767B2 (ja) | 2010-09-29 |
BR0316205A (pt) | 2005-09-27 |
WO2004043968A1 (en) | 2004-05-27 |
US7291734B2 (en) | 2007-11-06 |
TW200504081A (en) | 2005-02-01 |
AU2003288056A1 (en) | 2004-06-03 |
US20060247268A1 (en) | 2006-11-02 |
MY135750A (en) | 2008-06-30 |
PT1562958E (pt) | 2008-08-26 |
CA2505249A1 (en) | 2004-05-27 |
PE20040693A1 (es) | 2004-11-23 |
EP1562958A1 (de) | 2005-08-17 |
ES2305542T3 (es) | 2008-11-01 |
TWI318212B (en) | 2009-12-11 |
DE60321209D1 (de) | 2008-07-03 |
AR041952A1 (es) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE457980T1 (de) | Aryloxime | |
ATE534648T1 (de) | C-6-modifizierte indazolylpyrrolotriazine | |
DE50305852D1 (de) | Einspritzventil | |
DE50306589D1 (de) | Wischblatt | |
ATE318817T1 (de) | Aza-arylpiperazine | |
ATE427876T1 (de) | Luftkissenboot | |
DE50212360D1 (de) | Anfahrhilfesteuerungsvorrichtung | |
DE50212349D1 (de) | Hirurgie | |
DE50301200D1 (de) | Wischblatt | |
DE50305301D1 (de) | Einspritzventil | |
ATE349458T1 (de) | Etonogestrelester | |
DE50309536D1 (de) | Fadenabsaugvorrichtung | |
ATA1572002A (de) | Managementspleisskassette | |
DE50307971D1 (de) | Gelenklager | |
DE50301960D1 (de) | Hydrolager | |
DE50301464D1 (de) | Schraubensicherung | |
DE50309499D1 (de) | Librierwerkzeugen | |
DE50302660D1 (de) | Stopfmachine | |
ATA4142004A (de) | Trägerverbau | |
ATE469773T1 (de) | Zugöse | |
DE50305973D1 (de) | Auffangwanne | |
DE50303317D1 (de) | Einschub-leistungsschalter | |
ATA19152002A (de) | Hubkupplung | |
DE50308979D1 (de) | Einspritzventil | |
DE60321209D1 (de) | N-sulfonylaminothiazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1562958 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |